申联生物：2025年度净利润-1909.07万元

Group 1 - The core viewpoint of the article highlights that Shenlian Bio reported a revenue of approximately 288 million yuan for the year 2025, representing a year-on-year decrease of 4.99% [1] - The net profit attributable to shareholders of the listed company was a loss of 19.09 million yuan, compared to a loss of 44.74 million yuan in the same period last year [1] - The basic earnings per share for the company was a loss of 0.05 yuan, an improvement from a loss of 0.11 yuan in the previous year [1] Group 2 - The article also mentions a significant shift in AI usage, with China surpassing the United States in AI call volume, leading to a surge in various sectors in the A-share market [1] - A well-known Wall Street analyst commented on China's computing power path, suggesting it disrupts traditional perceptions [1]